RecruitingNCT07385170
Perioperative Continuous Glucose Monitoring Accuracy in Cardiac Surgery
Evaluation of Perioperative Continuous Glucose Monitoring Accuracy in Patients Undergoing Cardiac Surgery
Sponsor
Seoul National University Hospital
Enrollment
100 participants
Start Date
May 27, 2026
Study Type
OBSERVATIONAL
Conditions
Summary
The goal of this clinical trial is to evaluate accuracy of continuous glucose monitoring device called 'Dexcom G7' in patients undergoing cardiac surgery.
Eligibility
Min Age: 19 Years
Inclusion Criteria1
- Patients aged 19 years or older scheduled for cardiac surgery
Exclusion Criteria1
- Skin disease at the sensor application site (proximal arm)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEDexcom G7
Continuous glucose monitoring device (Dexcom G7) will be applied to patients undergoing cardiac surgery intraoperatively and postoperatively (maximum 10 days)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07385170
Related Trials
Fluid-removal Guided by VeXUS Score With Usual Care in Patients With Acute Kidney Injury After Cardiac Surgery
NCT062517132 locations
Impact of a Technology Platform Based on Enhanced Recovery After(ERAS) Surgery on Length of Stay After Coronary Artery Bypass Grafting: Timely Project
NCT067868192 locations
Assessment of a Multimodal Analgesia for Enhanced Recovery After Cardiac Surgery
NCT074174621 location
Appropriateness of Hemostatic Agent Use in Cardiovascular Surgery (HAEMOVAX)
NCT076990161 location
Serratus Posterior Superior Plane Block for Postoperative Pain in Cardiac Surgery
NCT071646771 location